Can a Blood Test Tell Your Biological Age?

1. Biological age vs chronological age — what's the difference?

Chronological age is a calendar fact. Biological age reflects the actual state of your cells, tissues, and organ systems — how much wear and tear has accumulated, how efficiently your body repairs damage, and how well your metabolic, immune, and hormonal systems are functioning.

The gap between the two is driven by genetics (~20–30%) and lifestyle (~70–80%). Smoking, poor sleep, chronic stress, processed diets, and sedentary behaviour accelerate biological ageing. Resistance training, adequate sleep, anti-inflammatory diets, and managing metabolic health slow it down.

This isn't abstract. A 2023 study in Communications Biology using 306,116 UK Biobank participants found that people whose biological age exceeded their chronological age by 5+ years had significantly higher rates of cardiovascular disease, cancer, and all-cause mortality — regardless of how healthy they appeared on standard clinical assessments.

The practical implication: if you can measure your biological age, you can track whether your lifestyle is accelerating or decelerating your ageing — and intervene before disease manifests.

2. Can a blood test actually measure biological age?

Yes — and this is the part most people don't realise. You don't need an expensive epigenetic test to get a meaningful estimate of your biological age. Algorithms validated on hundreds of thousands of people can calculate it from routine blood biomarkers that cost £50–£150 to test privately.

The most widely validated is PhenoAge, developed by Morgan Levine at Yale. It uses 9 standard blood biomarkers plus your chronological age to produce a “phenotypic age” score. When validated on the NHANES cohort of 11,000+ adults, each one-year increase in PhenoAge above chronological age corresponded to a 9% increase in all-cause mortality risk.

There are also epigenetic approaches (GrimAge, DunedinPACE) that analyse DNA methylation patterns. These are more precise but require specialised lab processing, cost £250–£700, and take 4–6 weeks for results. Blood biomarker-based estimation is faster, cheaper, and gives you actionable data on the specific systems driving your ageing — not just a single number.

3. PhenoAge: the 9-biomarker algorithm

PhenoAge was published in 2018 by Morgan Levine and colleagues in Aging. It works in two stages: first, 9 blood biomarkers are combined to predict 10-year mortality risk using a Cox proportional hazards model. Then, that mortality risk is converted into a “phenotypic age” — the chronological age at which your mortality risk would be average.

In plain English: if your blood results give you the mortality risk profile of an average 52-year-old, your PhenoAge is 52 — regardless of your birthday.

The 9 biomarkers PhenoAge uses are all standard clinical tests available at any NHS or private laboratory in the UK:

What makes PhenoAge powerful is that it captures ageing across multiple organ systems simultaneously. A single high CRP might mean a recent infection. But when CRP is elevated alongside rising glucose, declining albumin, and expanding red cell distribution width, the pattern reveals systemic ageing that no single marker would catch alone.

The UK Biobank validation confirmed that blood biomarker-based biological age predicted mortality and hospital admissions in 306,000+ British adults aged 38–73 — making this the largest UK-specific validation of any biological age algorithm.

4. GrimAge and DunedinPACE: the epigenetic clocks

While PhenoAge uses blood biomarkers directly, epigenetic clocks take a different approach: they measure chemical modifications (methylation) on your DNA. These modifications change predictably with age, and deviations from the expected pattern reveal accelerated or decelerated ageing.

GrimAge (published in 2019) uses DNA methylation data to estimate levels of 7 plasma proteins associated with mortality, plus smoking pack-years. A validation study found a two-fold increase in all-cause mortality for each standard deviation of GrimAge acceleration. It predicted 8 of 9 clinical outcomes tested, including walking speed, cognitive decline, and frailty.

DunedinPACE (2022) measures the pace of ageing rather than total accumulated damage. It was developed from the Dunedin Longitudinal Study, which tracked 1,037 people from birth. A score of 1.0 means you're ageing at the expected rate. Below 1.0 means you're ageing slower than your peers; above 1.0, faster. The key advantage: DunedinPACE is sensitive to lifestyle interventions, meaning it can detect whether changes you've made are actually slowing your ageing within months, not years.

5. Blood biomarkers vs DNA methylation vs glycan testing

There are three main commercial approaches to measuring biological age in the UK. Each measures something different, and none is a complete picture on its own.

Blood biomarkers are the most practical starting point for most people. They're the cheapest, fastest, and — crucially — they tell you which systems are driving your ageing. If your CRP is elevated, you know inflammation is a problem. If your HbA1c is climbing, metabolic health is the priority. An epigenetic clock gives you a single number but doesn't tell you what to fix.

DNA methylation tests are the gold standard for precision but require a blood sample sent to a US lab (TruDiagnostic) or similar. No UK-based lab currently offers commercial epigenetic age testing. The 4–8 week turnaround and higher cost make them better suited as an annual or biannual complement rather than a primary monitoring tool.

Glycan testing measures one specific dimension of ageing: immune system function via IgG glycosylation. It's responsive to lifestyle changes (particularly diet and exercise) but only captures inflammatory/immune ageing — it won't flag metabolic, cardiovascular, or hormonal issues.

6. The 9 biomarkers that predict your biological age

These are the biomarkers used in the PhenoAge algorithm, grouped by the system they reflect. Together, they form a multi-system snapshot of how quickly you're ageing. Several overlap with markers in our blood test panels.

Inflammation

High-sensitivity CRP (hs-CRP) is the single strongest inflammatory predictor in PhenoAge. Chronic low-grade inflammation — sometimes called “inflammaging” — accelerates ageing across every organ system. Optimal is below 1.0 mg/L. Above 3.0 mg/L is associated with doubled cardiovascular risk according to NICE cardiovascular guidelines. White blood cell count provides a complementary measure of immune activation.

Metabolic health

Fasting glucose reflects short-term blood sugar regulation. Insulin resistance is one of the most powerful drivers of accelerated ageing, damaging blood vessels, promoting inflammation, and impairing cellular repair. If you want deeper metabolic insight, HbA1c (which reflects your average blood sugar over 3 months) is an even more stable marker and is included in our Performance panel.

Liver function

Albumin and alkaline phosphatase both reflect liver health. Declining albumin is one of the most consistent predictors of mortality in older adults — it signals reduced protein synthesis capacity and systemic decline. ALT is another liver marker worth tracking alongside these, as it detects fatty liver disease — a condition affecting roughly 1 in 3 UK adults.

Kidney function

Creatinine is used to calculate eGFR (estimated glomerular filtration rate), the gold-standard measure of kidney function. The UK Biobank biological age study found cystatin C (a more sensitive kidney marker) to be the single strongest predictor of biological age across all 25 biomarkers tested. Kidney function declines silently — most people don't notice until 60–70% of function is lost.

Immune system

Lymphocyte percentage and white blood cell count reflect your adaptive and innate immune function respectively. As you age, your immune system undergoes “immunosenescence” — a gradual decline in immune competence. Low lymphocyte percentages in younger adults are particularly predictive of accelerated ageing.

Blood cell health

Mean cell volume (MCV) and red cell distribution width (RDW) are part of a standard full blood count. RDW in particular has emerged as a surprisingly powerful mortality predictor — elevated RDW is associated with cardiovascular disease, cancer, and all-cause mortality even in apparently healthy people. It reflects underlying iron deficiency, B12/folate deficiency, or chronic inflammation.

7. What the NHS Health Check covers — and what it misses

The NHS Health Check is a free screening offered to everyone in England aged 40–74, once every 5 years. It's a valuable baseline, but it wasn't designed to measure biological age.

The NHS Health Check calculates a 10-year cardiovascular risk score using QRISK3. This is genuinely useful — cardiovascular disease is the UK's leading killer. But it only captures one dimension of ageing. It won't detect accelerated ageing driven by chronic inflammation, metabolic dysfunction, immune decline, or organ stress.

If you're under 40, you won't even be offered an NHS Health Check. And if you're over 40, once every 5 years is too infrequent to detect meaningful trends. This is where private blood testing fills the gap — not as a replacement for NHS care, but as a complement that catches what routine screening doesn't.

8. How to get tested in the UK (and what it costs)

Here's a realistic breakdown of what biological age testing costs in the UK in 2026:

Our recommendation: start with a comprehensive blood panel. It gives you the most actionable data at the lowest cost. If your results show accelerated ageing, address the specific biomarkers flagged. Consider adding an epigenetic test after 6–12 months to validate your progress with a different measurement approach.

9. What your biological age result actually means

Let's be honest about what these numbers can and cannot tell you. A biological age estimate is not a precise medical diagnosis. It's a validated risk score — a statistical estimate based on how people with similar biomarker profiles have fared in large population studies.

The most valuable insight isn't a single number — it's the trend over time. Is your biological age getting further from or closer to your chronological age? Two data points 6 months apart tell you more than one data point at maximum precision.

10. Evidence-based ways to lower your biological age

These interventions have evidence for reversing biological age acceleration, measured by either blood biomarker algorithms or epigenetic clocks:

11. How often should you retest?

Biological age changes slowly. Testing too frequently wastes money; testing too rarely misses the trend.

Frequently asked questions